Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

EMILY M BECKER

Allopathic & Osteopathic Physicians Dermatology

NPI
1265619217
CMS profile
193711
Location
SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$403,203.79

298 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 6; records 101–150 of 298 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

EMILY M BECKER

NPI 1265619217 · CMS profile ID 193711

Allopathic & Osteopathic Physicians / Dermatology

SAN ANTONIO, TX

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 6; records 101–150 of 298 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1265619217?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
EMILY M BECKER, NPI 1265619217, CMS profile ID 193711. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 298 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1265619217?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). EMILY M BECKER, NPI 1265619217, CMS profile ID 193711. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 6; records 101–150 of 298 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1265619217?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
EMILY M BECKER, NPI 1265619217, CMS profile ID 193711, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 6; records 101–150 of 298 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1265619217?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

298 matching records · $403,203.79 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 298 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 298.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Incyte Corporation $77.2507/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226020201 CMS
Incyte Corporation $23.4507/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226020225 CMS
Incyte Corporation $80.7507/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1226020171 CMS
Regeneron Healthcare Solutions, Inc. $1,299.7907/22/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871059 CMS
Krystal Biotech Inc $29.3307/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199995474 CMS
Regeneron Healthcare Solutions, Inc. $1,144.0007/18/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871053 CMS
Regeneron Healthcare Solutions, Inc. $99.2907/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871055 CMS
Regeneron Healthcare Solutions, Inc. $8,967.0007/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871057 CMS
Regeneron Healthcare Solutions, Inc. $333.8707/17/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871051 CMS
Regeneron Healthcare Solutions, Inc. $7.0907/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871049 CMS
GENZYME CORPORATION $36.4607/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233449289 CMS
Amgen Inc. $16.4507/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1228664203 CMS
Arcutis Biotherapeutics, Inc. $2,250.0007/09/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1252340870 CMS
Arcutis Biotherapeutics, Inc. $6,187.5007/09/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1252340876 CMS
GENZYME CORPORATION $4,697.0007/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233449291 CMS
Krystal Biotech Inc $6.5007/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1199995472 CMS
Regeneron Healthcare Solutions, Inc. $392.4707/02/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871045 CMS
Regeneron Healthcare Solutions, Inc. $155.8007/02/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871047 CMS
GENZYME CORPORATION $124.9807/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233449293 CMS
GENZYME CORPORATION $4,697.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1233449295 CMS
Regeneron Healthcare Solutions, Inc. $3,843.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871035 CMS
Regeneron Healthcare Solutions, Inc. $3,843.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871037 CMS
Regeneron Healthcare Solutions, Inc. $3,843.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871039 CMS
Regeneron Healthcare Solutions, Inc. $10,675.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871041 CMS
Regeneron Healthcare Solutions, Inc. $3,843.0007/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871043 CMS
Galderma Laboratories, L.P. $7.1506/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234617990 CMS
Organon LLC $6.0006/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1237682444 CMS
Lilly USA, LLC $2,500.0006/27/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186575516 CMS
Regeneron Healthcare Solutions, Inc. $122.4606/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871033 CMS
Regeneron Healthcare Solutions, Inc. $378.8806/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871031 CMS
Arcutis Biotherapeutics, Inc. $138.9106/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252340866 CMS
Arcutis Biotherapeutics, Inc. $103.1006/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252340872 CMS
Arcutis Biotherapeutics, Inc. $92.0806/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252340874 CMS
Arcutis Biotherapeutics, Inc. $395.9606/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1252340864 CMS
Arcutis Biotherapeutics, Inc. $303.9706/20/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1252340868 CMS
PFIZER INC. $18.9306/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1231310994 CMS
Regeneron Healthcare Solutions, Inc. $6,619.0006/17/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1212871029 CMS
Lilly USA, LLC $950.0006/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186596478 CMS
Lilly USA, LLC $2,500.0006/06/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1186646981 CMS
Regeneron Healthcare Solutions, Inc. $68.1406/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871015 CMS
Regeneron Healthcare Solutions, Inc. $67.5806/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871017 CMS
Regeneron Healthcare Solutions, Inc. $26.5006/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871019 CMS
Regeneron Healthcare Solutions, Inc. $256.3206/05/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871021 CMS
Regeneron Healthcare Solutions, Inc. $26.9006/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871023 CMS
Regeneron Healthcare Solutions, Inc. $46.3806/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871025 CMS
Regeneron Healthcare Solutions, Inc. $363.9606/05/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1212871027 CMS
Lilly USA, LLC $99.9906/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186646983 CMS
PFIZER INC. $770.0006/02/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1231341043 CMS
Incyte Corporation $25.3605/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226116941 CMS
Regeneron Healthcare Solutions, Inc. $10.9505/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212871013 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $161,309.03 197
PY2020 $53,097.25 68
PY2021 $87,570.65 87
PY2022 $182,207.18 154
PY2023 $89,653.62 88
PY2024 $266,068.88 242
PY2025 $403,203.79 298

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $130,576.56 10
PY2024 Recipient $1,006.34 5
PY2024 Principal investigator $246,845.79 11
PY2023 Principal investigator $76,185.43 5
PY2022 Principal investigator $117,103.84 4
PY2021 Principal investigator $335,452.06 6
PY2020 Principal investigator $255,525.35 34
PY2019 Recipient $4,010.00 1
PY2019 Principal investigator $4,471.99 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $19,322.00 12/11/2025 Covered Recipient Teaching Hospital
DRISCOLL CHILDRENS HOSPITAL
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RITLECITINIB IN PEDIATRIC PARTICIPANTS 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA No dispute reported 06/30/2026 1228750047
Principal investigator 1 SANOFI US SERVICES INC. $250.00 10/20/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=6 Months to <18 Years of Age With Prurigo Nodularis No dispute reported 06/30/2026 1226154234
Principal investigator 1 Amgen Inc. $245.00 09/25/2025 Non-covered Recipient Entity
DRISCOLL CHILDRENS HOSPITAL
A Phase 3b, Multi Center, Open-label, Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1246640871
Principal investigator 1 SANOFI US SERVICES INC. $187.50 08/25/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=6 Months to <18 Years of Age With Prurigo Nodularis No dispute reported 06/30/2026 1226154229
Principal investigator 1 SANOFI US SERVICES INC. $125.00 07/21/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=6 Months to <18 Years of Age With Prurigo Nodularis No dispute reported 06/30/2026 1226154224
Principal investigator 1 SANOFI US SERVICES INC. $2,000.00 06/18/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=6 Months to <18 Years of Age With Prurigo Nodularis No dispute reported 06/30/2026 1226139492
Principal investigator 1 Amgen Inc. $47,408.80 04/24/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Phase 3b, Multi Center, Open-label, Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis No dispute reported 06/30/2026 1246638120
Principal investigator 1 SANOFI US SERVICES INC. $18,088.00 03/28/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants >=6 Months to <18 Years of Age With Prurigo Nodularis No dispute reported 06/30/2026 1226139395
Principal investigator 1 Amgen Inc. $6,300.00 03/25/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Phase 3, Open-label, 52-week Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adolescent Subjects Aged ? 12 to < 18 Years With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit) No dispute reported 06/30/2026 1246638118
Principal investigator 1 Amgen Inc. $36,650.26 01/27/2025 Covered Recipient Teaching Hospital
Driscoll Childrens Hospital
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) No dispute reported 06/30/2026 1246638116